CD39 is a promising therapeutic antibody target for the treatment of soft tissue sarcoma

Soft tissue sarcoma (STS) is a heterogenous tumor arising from the embryonic mesoderm represented by approximately 50 histological subtypes. Effective therapeutic intervention is lacking for recurrent, late stage and metastatic disease. CD39, a cell-surface ectonucleotidase, has previously been show...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Transl Res
Main Authors: Hayes, Gregory M, Cairns, Belinda, Levashova, Zoia, Chinn, Lawrence, Perez, Myra, Theunissen, Jan-Willem, Liao-Chan, Sindy, Bermudez, Abel, Flory, Mark R, Schweighofer, Karl J, H van der Horst, Edward
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4532750/
https://ncbi.nlm.nih.gov/pubmed/26279761
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados